Neglected brain region could play a critical role in drug relapse

Rally­bio is lay­ing off close to half of its em­ploy­ees and seek­ing “al­ter­na­tive op­tions” for its pre­clin­i­cal pro­grams as it gets ready to put the

Cel­lares an­nounced a new part­ner­ship with Ca­balet­ta Bio to man­u­fac­ture the biotech’s au­toim­mune CAR-T cell ther­a­py can­di­date through mid-stage clin­i­cal tri­als. Us­ing its Cell Shut­tle